MARKET

GKOS

GKOS

Glaukos
NYSE

Real-time Quotes | Nasdaq Last Sale

63.78
+1.08
+1.72%
After Hours: 63.78 0 0.00% 16:52 11/15 EST
OPEN
63.27
PREV CLOSE
62.70
HIGH
64.27
LOW
62.87
VOLUME
408.36K
TURNOVER
--
52 WEEK HIGH
84.65
52 WEEK LOW
50.60
MARKET CAP
2.36B
P/E (TTM)
-120.9329
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of GKOS and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 9 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

GKOS News

  • Glaukos Corporation 2019 Q3 - Results - Earnings Call Presentation
  • Seeking Alpha - Article.1d ago
  • Edited Transcript of GKOS earnings conference call or presentation 6-Nov-19 9:30pm GMT
  • Thomson Reuters StreetEvents.3d ago
  • Investors Who Bought Glaukos (NYSE:GKOS) Shares Three Years Ago Are Now Up 84%
  • Simply Wall St..4d ago
  • Glaukos (GKOS) Q3 Loss Narrower Than Expected, '19 View Up
  • Zacks.11/08 14:08

More

Industry

Medical Equipment, Supplies & Distribution
+1.04%
Healthcare Equipment & Supplies
+1.69%

Hot Stocks

Name
Price
%Change

About GKOS

Glaukos Corporation is an ophthalmic medical technology company. The Company focuses on the development and commercialization of products and procedures for the treatment of glaucoma. It offers iStent, a micro-invasive glaucoma surgery (MIGS) device. The iStent is a micro-bypass stent inserted through the small corneal incision made during cataract surgery and placed into Schlemm's canal, a circular channel in the eye that collects aqueous humor and delivers it back into the bloodstream. It is developing three additional pipeline products: the iStent Inject, the iStent Supra and iDose. The iStent Inject includes two stents pre-loaded in an auto-injection inserter. The iStent Supra is designed to access an alternative drainage space within the eye. iDose is a drug delivery system that is designed to be implanted in the eye to continuously deliver therapeutic levels of medication for extended periods of time to lower intraocular pressure in glaucoma patients.
More

Webull offers Glaukos Corp (GKOS) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.